Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.006 AUD 0.00(0%)
Last update at 2026-11-06T03:52:00Z
VOLUME
2770732
Market Cap
2.27M

Momentum Score

…

Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the manufacture and distribution of hemp-derived cannabidiol (CBD) products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is based in Newtown, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Elixinol Wellness Ltd manufactures and sells hemp-derived CBD and plant-based wellness products to consumer health markets in Australia and selected international channels. Long-term growth may be supported by rising consumer acceptance of CBD, expansion of e-commerce and retail distribution, and ongoing product development, which may make the company attractive to investors seeking exposure to the consumer wellness segment.

Principal risks are regulatory uncertainty for CBD products, strong competition in the nutraceuticals market, and execution or supply-chain challenges that could impair revenue and margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
15.90M
Revenue Per Share
0.04
Gross Profit TTM
6.76M
Debt / Equity
0.53
ROE
-53.00%
Net Debt
2.54M
ROCE
-53.38%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.04M -5.31M -7.50M -10.57M -17.09M
Net income -5.50M -1.72M -7.51M -10.57M -17.02M
Selling general administrative - 5.48M 6.17M 8.08M 12.95M
Selling and marketing expenses - 2.39M 1.82M 2.29M 3.68M
Gross profit 0.75M 5.36M -1.80M 3.24M 4.90M
Reconciled depreciation - 1.04M 0.60M 0.72M 2.30M
Ebit -4.98M -5.05M -7.40M -9.01M -11.67M
Ebitda -4.11M -4.01M -6.81M -8.29M -10.18M
Depreciation and amortization 0.87M 1.04M 0.60M 0.72M 1.49M
Operating income -4.98M -3.47M -6.43M -9.01M -11.67M
Other operating expenses 20.48M 18.42M 14.73M 17.06M 24.95M
Interest expense 0.49M 0.21M 0.10M -0.05M 5.42M
Tax provision - -3.59M 0.00M 0.00M -0.07M
Interest income - 0.03M 0.21M 0.02M 0.01M
Net interest income - -0.18M 0.11M -0.05M -0.06M
Income tax expense -0.54M -3.59M 0.00M 0.00M -0.07M
Total revenue 15.50M 14.96M 8.27M 7.05M 9.34M
Total operating expenses 5.73M 8.82M 9.88M 13.24M 20.50M
Cost of revenue 14.75M 9.60M 10.07M 3.82M 4.44M
Total other income expense net -1.06M -1.84M -1.04M -1.56M -5.42M
Net income from continuing ops - -1.72M -7.51M -10.57M -27.85M
Net income applicable to common shares - -1.72M -7.51M -10.57M -17.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 15.96M 18.45M 11.71M 13.48M 25.33M
Intangible assets 2.02M 4.81M - 0.15M 0.46M
Other current assets 0.45M 0.91M 2.08M 0.17M 0.17M
Total liab 8.51M 8.42M 5.25M 4.33M 6.25M
Total stockholder equity 7.45M 10.03M 6.46M 9.16M 19.08M
Other current liab 1.67M 1.87M 1.64M 1.35M 1.10M
Common stock 229.88M 228.29M 222.57M 218.12M 218.06M
Capital stock - - - 218.12M 218.06M
Retained earnings -233.29M -227.88M -226.15M -218.65M -208.07M
Good will 3.13M 1.37M - - 0.00M
Other assets - - 0.00M 0.08M 0.18M
Cash 1.41M 1.08M 0.71M 2.86M 12.65M
Total current liabilities 6.64M 4.99M 4.99M 3.44M 4.71M
Current deferred revenue 0.05M - 0.52M - 1.07M
Net debt 2.54M 0.86M 0.55M -0.96M -9.93M
Short term debt 3.40M 1.30M 1.07M 1.02M 1.18M
Short long term debt - - - 0.32M 0.43M
Short long term debt total 3.95M 1.94M 1.26M 1.90M 2.71M
Other stockholder equity - - - 9.09M 9.09M
Property plant equipment - - - 1.11M 2.48M
Total current assets 5.70M 7.18M 8.18M 9.31M 19.59M
Long term investments - - - 2.83M 2.62M
Net tangible assets - - - 9.01M 18.61M
Short term investments - - - 0.17M 0.17M
Net receivables 1.19M 1.30M 1.72M 3.97M 2.97M
Long term debt - - - 0.25M 0.25M
Inventory 2.66M 3.89M 3.66M 1.74M 2.20M
Accounts payable 1.52M 1.82M 1.76M 1.08M 1.36M
Accumulated other comprehensive income 10.87M 9.61M 10.04M 9.68M 9.09M
Non currrent assets other 0.08M 3.67M 2.35M 0.08M 0.18M
Non current assets total 10.26M 11.27M 3.54M 4.17M 5.74M
Capital lease obligations - - - 1.33M 2.04M
Long term debt total - - - 0.82M 1.47M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.07M -1.04M -0.87M -0.01M
Change to liabilities - - - -0.90M -0.61M
Total cashflows from investing activities -0.22M -0.07M -1.04M -0.87M 0.17M
Net borrowings - 0.86M 0.30M -0.76M -1.05M
Total cash from financing activities 3.65M 3.92M 1.61M -0.76M -1.16M
Change to operating activities - - - 0.23M 0.35M
Net income -5.50M -1.72M -7.51M -10.57M -27.85M
Change in cash 0.33M 0.37M -2.16M -9.79M -15.09M
Begin period cash flow 1.08M 0.71M 2.86M 12.65M 27.74M
End period cash flow 1.41M 1.08M 0.71M 2.86M 12.65M
Total cash from operating activities -3.21M -3.47M -2.76M -9.85M -14.07M
Issuance of capital stock - 4.66M 2.25M - -
Depreciation 0.87M 1.04M 0.60M 0.72M 1.49M
Other cashflows from investing activities 0.00M 2.27M -1.22M -0.86M 0.46M
Change to inventory 1.23M 1.73M 0.47M 0.23M -0.24M
Change to account receivables 0.42M 0.54M 1.37M 0.14M -2.01M
Sale purchase of stock - -0.56M -0.20M - -0.11M
Other cashflows from financing activities -0.30M -1.04M -0.74M -0.76M -1.05M
Change to netincome - - - 1.52M 4.02M
Capital expenditures 0.07M 0.06M 0.02M 0.01M 0.29M
Change in working capital 0.75M 1.49M 1.97M 0.39M 0.41M
Stock based compensation - 0.05M 0.68M - -
Other non cash items 0.66M -4.28M 1.51M 9.85M 26.36M
Free cash flow -3.28M -3.53M -2.77M -9.86M -14.36M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
EXL
Elixinol Wellness Ltd
-
-%
0.01 - 125.00 0.14 0.43 0.38 -0.71
AFP
Aft Pharmaceuticals Ltd
-
-%
3.59 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd
-
-%
2.70 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd
-
-%
0.06 - 10.00 0.64 0.60 1.25 19.47
MVP
Medical Developments International Ltd
-
-%
0.40 40.00 166.67 1.06 0.79 0.57 7.45

Profile*

Elixinol Wellness Ltd

Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the manufacture and distribution of hemp-derived cannabidiol (CBD) products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is based in Newtown, Australia.

51 - 53 Riversdale Road, Newtown, VIC, Australia, 3220

61 2 4044 4585

Name Title Year Born
Mr. Ronald Dufficy BEC, FCPA Interim Global Chief Exec. Officer NA
Ms. Josephine Lorenz Global CFO & Group Financial Controller NA
Glen Zurcher Account Director of Investor Relations Department NA
Ms. Teresa Cleary Gen. Counsel & Company Sec. NA
Mr. Rob Hasselman Pres of Americas NA
Ms. Beata Silber Global Head of R&D and Innovation NA
Ms. Kim Bradley-Ware Joint Company Sec. NA
Mr. Ronald Dufficy BEC, FCPA Group CEO, MD & Director NA
Ms. Josephine Lorenz Global CFO, Group Financial Controller & Joint Company Secretary NA
Mr. Rob Hasselman President of Americas NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…